These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 692285)

  • 1. Investigations concerning the cellular origin of dopamine receptors.
    Henn FA; Titeler M; Anderson DJ; May K
    Life Sci; 1978 Aug; 23(6):617-21. PubMed ID: 692285
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
    Nagy JI; Lee T; Seeman P; Fibiger HC
    Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 4. Affinities of drugs for the agonist and antagonist states of the dopamine receptor.
    Riddall DR; Leavens WJ
    Eur J Pharmacol; 1978 Sep; 51(2):187-8. PubMed ID: 699984
    [No Abstract]   [Full Text] [Related]  

  • 5. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.
    Murrin LC; Gale K; Kuhar MJ
    Eur J Pharmacol; 1979 Dec; 60(2-3):229-35. PubMed ID: 43260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
    Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
    Quik M; Spokes EG; Mackay AV; Bannister R
    J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of [3H]apomorphine binding to bovine brain tissue.
    Arana GW; Baldessarini RJ; Harding M
    Biochem Pharmacol; 1981 Dec; 30(23):3171-9. PubMed ID: 7317102
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
    Clement-Cormier YC; George RJ
    J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease: low density and presynaptic location of D3 dopamine receptors.
    Lee T; Seeman P; Hornykiewicz O; Bilbao J; Deck J; Tourtellotte WW
    Brain Res; 1981 May; 212(2):494-8. PubMed ID: 7225883
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective labeling of apomorphine receptors by 3H-LSD.
    Whitaker PM; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic and postsynaptic D1 dopamine receptors in the nigrostriatal system of the rat brain: a quantitative autoradiographic study using the selective D1 antagonist [3H]SCH 23390.
    Filloux FM; Wamsley JK; Dawson TM
    Brain Res; 1987 Apr; 408(1-2):205-9. PubMed ID: 2954613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptors in rat frontal cortex: pharmacological properties in vivo and in vitro.
    Bacopoulos NG; Ware PL
    Life Sci; 1980 Dec 22-29; 27(25-26):2489-94. PubMed ID: 6163938
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine.
    Titeler M; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):291-2. PubMed ID: 477726
    [No Abstract]   [Full Text] [Related]  

  • 20. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I; Snyder SH
    Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.